Cholestanetriol 26-Monooxygenase
"Cholestanetriol 26-Monooxygenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An NAPH-dependent cytochrome P450 enzyme that catalyzes the oxidation of the side chain of sterol intermediates such as the 27-hydroxylation of 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol.
| Descriptor ID |
D053493
|
| MeSH Number(s) |
D08.244.453.499.750 D08.244.453.915.149 D08.811.682.690.708.170.493.750 D08.811.682.690.708.170.915.150 D12.776.422.220.453.499.750 D12.776.422.220.453.915.150
|
| Concept/Terms |
Cholestanetriol 26-Monooxygenase- Cholestanetriol 26-Monooxygenase
- Cholestanetriol 26 Monooxygenase
- C27-Steroid 26-Hydroxylase
- C27 Steroid 26 Hydroxylase
- Cytochrome P-450 Sterol 26-Hydroxylase
- Cytochrome P 450 Sterol 26 Hydroxylase
- 5-beta-Cholestane-3-alpha,7-alpha,12-alpha-triol 27-Hydroxylase
- Steroid 27-Hydroxylase
- Steroid 27 Hydroxylase
- Sterol 27-Hydroxylase
- Sterol 27 Hydroxylase
- Vitamin D3 25-Hydroxylase
- Vitamin D3 25 Hydroxylase
- Sterol 26-Hydroxylase
- Sterol 26 Hydroxylase
- Steroid 25-Hydroxylase
- Steroid 25 Hydroxylase
- Cytochrome P-450 Steroid 27-Hydroxylase
- Cytochrome P 450 Steroid 27 Hydroxylase
|
Below are MeSH descriptors whose meaning is more general than "Cholestanetriol 26-Monooxygenase".
Below are MeSH descriptors whose meaning is more specific than "Cholestanetriol 26-Monooxygenase".
This graph shows the total number of publications written about "Cholestanetriol 26-Monooxygenase" by people in this website by year, and whether "Cholestanetriol 26-Monooxygenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholestanetriol 26-Monooxygenase" by people in Profiles.
-
Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies. Genet Med. 2024 05; 26(5):101086.
-
Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control. 2014 May; 25(5):561-70.
-
Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress. Redox Rep. 2007; 12(3):119-24.
-
A novel mutation in the sterol 27-hydroxylase gene of a Pakistani family with autosomal recessive cerebrotendinous xanthomatosis. Neurology. 1997 Jan; 48(1):258-60.
-
Loss of parathyroid hormone-stimulated 1,25-dihydroxyvitamin D3 production in aging does not involve protein kinase A or C pathways. J Bone Miner Res. 1994 Mar; 9(3):339-45.
-
24-Dehydrovitamin D is potent inhibitor of rat liver microsomal vitamin D-25-hydroxylase. Arch Biochem Biophys. 1988 Nov 01; 266(2):532-8.
-
Suppression of rat hepatic vitamin D-25-hydroxylase by cholecalciferol, but not by 25-hydroxy- or 1,25-dihydroxymetabolites. Calcif Tissue Int. 1988 Apr; 42(4):273-8.
-
Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salts. Hepatology. 1981 Sep-Oct; 1(5):436-40.